FDA Orange Book
Is there a generic for Vonjo?
Vonjo contains pacritinib. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Vonjo (pacritinib). The Orange Book shows its last listed patent expires March 25, 2030 and its last listed exclusivity ends February 28, 2029.
Run it in Rivvi
Map Vonjo and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Vonjo products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| capsule, oral | EQ 100MG BASE | Marketed (Rx) | None | 0 | None |
NDA 208712, held by SOBI INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Vonjo patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 9573964 | May 5, 2028 | Method of use | U-3332 | 208712 |
| 9573964 | May 5, 2028 | Method of use | U-3331 | 208712 |
| 8153632 | January 17, 2029 | Drug substance, Drug product | U-3332 | 208712 |
| 8153632 | January 17, 2029 | Drug substance, Drug product | U-3331 | 208712 |
| 8980873 | March 25, 2030 | Drug substance, Drug product | U-3331 | 208712 |
| 8980873 | March 25, 2030 | Drug substance, Drug product | U-3332 | 208712 |
Vonjo exclusivity
| Code | Meaning | Expires | NDA |
|---|---|---|---|
| NCE | New chemical entity | February 28, 2027 | 208712 |
| ODE-397 | Orphan drug exclusivity | February 28, 2029 | 208712 |
Vonjo NDC codes
Questions
Is there a generic for Vonjo?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Vonjo (pacritinib). The Orange Book shows its last listed patent expires March 25, 2030 and its last listed exclusivity ends February 28, 2029.
What is the generic name for Vonjo?
The active ingredient in Vonjo is pacritinib, per the FDA Orange Book.
When does the Vonjo patent expire?
The last patent listed for Vonjo in the Orange Book expires March 25, 2030. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.